Tagged with B

Life Sciences Wayne Samuels, partner at PwC Canada, discusses the most pressing issues in the country’s healthcare system and pharmaceutical industry, and outlines the changing dynamics in Canada’s pharma business model. What have been some of the key developments in life sciences during your tenure at PwC Canada so far? The most…

APL Care With over 6,000 inhabited islands forming the country of Indonesia, making sure that drugs are where they are needed, when they are needed, is a major challenge. How is this challenge managed today, and what will happen once the government introduces universal healthcare in January 2014? A manager that won…

liposome A 2006 article in CommonWealth Magazine detailing the genesis of this company reported that TLC had managed to “break out from the typical dilemma of ordinary biotech firms—to either engage in low cost, high competition generic drug manufacturing or expensive, time-consuming new drug development—by opening up a third road of…

Pharmaceutical Industry Technology and Development Center (PITDC) The president of Pharmaceutical Industry Technology and Development Center (PITDC) considers the company’s need to remain an international competitor and how to achieve it, the gap in new drug development in Taiwan, and PITDC’s mission to bring the country’s domestic companies to the international level. What are your thoughts on…

International Research-Based Pharmaceutical Manufacturers’ Association (IRPMA) General Manager, Chugai Pharma Taiwan and President of International Research-Based Pharmaceutical Manufacturers’ Association (IRPMA), discusses the continuous price cuts that plague the Taiwan market, and how IRPMA is getting involved in the discussions with the government on how to rectify this growing problem. During our interviews, general managers heading IRPMA…

Array The CEO of ASLAN Pharmaceuticals discusses the fundamental changes that need to occur in the treatment of serious illnesses, the advantages of building a second branch in Taiwan, and the key differences between the industry in Taiwan and Singapore. ASLAN is busy setting up a subsidiary in Taiwan. What attracted…

Biopharmaceutical Kevin Leshuk, Vice-President and General Manager of Celgene in Canada, offers his critique of the Canadian reimbursement and approval process as well as the advantages his affiliate enjoys in specialty pharma using Canada’s strong clinical base. What do Canadian biopharmaceutical companies offer as a competitive edge? I believe we have…

Biopharmaceutical Hervé Lilliu, General Manager of UCB Canada, describes Canada’s need to support the global pharma-ceutical industry rather than vice versa, and highlights examples of ways in which Canada’s slumbering R&D investment levels can be brought back to the country. What was your initial mandate upon arriving at UCB and what…

Biomedical The chairman of Taipei Medical University (TMU) discusses the key challenges TMU has faced over the years, how these challenges will continue to affect the future, and what international accreditation will mean for the collaboration of TMU with international pharmaceutical companies. Taipei Medical University (TMU) has a long history in…

Abnova Chairman of Abnova Corporation Wilber Huang discusses the company’s core strengths, Taiwan’s bilateral relationship with China’s biotech industry, and offers some advice to future start-up biotech companies in Taiwan. Abnova was founded during a very exciting time in the biotech industry. Can you tell us a bit more about what…

Bionet Corp. The chairman of Bionet reflects on past market challenges and the growing strength of Bionet’s reach both domestically and globally, and why Taiwan is the perfect size for a biotech start-up, despite its strict regulatory environment. Bionet is a cord blood banking pioneer in Taiwan. What is the story of…

health insurance Taiwan’s current health minister reflects on Taiwan’s prestigious healthcare system, the problems in the first generation health insurance system that were fixed in the second, and strategies to rectify the continuous problem of price cuts. Shortly following our interview, the heretofore-Department of Health will become the Ministry of Health and…